Vivani Medical, Inc. (VANI)
NASDAQ: VANI · IEX Real-Time Price · USD
1.630
-0.065 (-3.83%)
At close: Apr 26, 2024, 4:00 PM
1.610
-0.020 (-1.23%)
After-hours: Apr 26, 2024, 7:50 PM EDT
Vivani Medical Market Cap
Vivani Medical has a market cap or net worth of $89.61 million as of April 26, 2024. Its market cap has increased by 75.71% in one year.
Market Cap
89.61M
Enterprise Value
88.32M
1-Year Change
75.71%
Ranking
Category
Stock Price
$1.63
Market Cap Chart
Since November 19, 2014, Vivani Medical's market cap has decreased from $163.40M to $89.61M, a decrease of -45.16%. That is a compound annual growth rate of -6.17%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2024 | 93.20M | -2.00% |
Apr 24, 2024 | 95.10M | -3.94% |
Apr 23, 2024 | 99.00M | 7.84% |
Apr 22, 2024 | 91.80M | -1.82% |
Apr 19, 2024 | 93.50M | -5.75% |
Apr 18, 2024 | 99.20M | -1.98% |
Apr 17, 2024 | 101.20M | -4.17% |
Apr 16, 2024 | 105.60M | -4.95% |
Apr 15, 2024 | 111.10M | -2.37% |
Apr 12, 2024 | 113.80M | 0.98% |
Apr 11, 2024 | 112.70M | -0.53% |
Apr 10, 2024 | 113.30M | 0.53% |
Apr 9, 2024 | 112.70M | -6.01% |
Apr 8, 2024 | 119.90M | 9.00% |
Apr 5, 2024 | 110.00M | - |
Apr 4, 2024 | 110.00M | -1.70% |
Apr 3, 2024 | 111.90M | 8.22% |
Apr 2, 2024 | 103.40M | -5.05% |
Apr 1, 2024 | 108.90M | 7.08% |
Mar 28, 2024 | 101.70M | - |
Mar 27, 2024 | 101.70M | -1.64% |
Mar 26, 2024 | 103.40M | 5.51% |
Mar 25, 2024 | 98.00M | -4.02% |
Mar 22, 2024 | 102.10M | -1.45% |
Mar 21, 2024 | 103.60M | 1.47% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BioXcel Therapeutics | 94.01M |
Vigil Neuroscience | 93.96M |
Elicio Therapeutics | 93.01M |
Elutia | 92.79M |
Allurion Technologies | 91.88M |
Abeona Therapeutics | 89.45M |
PMV Pharmaceuticals | 89.25M |
Allakos | 89.19M |